Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether, after a period of abstinence, adding 6
weeks of gabapentin (a medication approved to treat seizures) to a standard 16-week
naltrexone (an opiate blocking agent approved for the treatment of alcohol dependence)
treatment protocol is helpful in decreasing relapse to drinking compared to naltrexone alone
or placebo. All participants will receive alcohol counseling.
Phase:
Phase 3
Details
Lead Sponsor:
Medical University of South Carolina
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)